Design and synthesis of phenylpiperazine derivatives as potent anticancer agents for prostate cancer. (19th June 2019)
- Record Type:
- Journal Article
- Title:
- Design and synthesis of phenylpiperazine derivatives as potent anticancer agents for prostate cancer. (19th June 2019)
- Main Title:
- Design and synthesis of phenylpiperazine derivatives as potent anticancer agents for prostate cancer
- Authors:
- Demirci, Serpil
Hayal, Taha Bartu
Kıratlı, Binnur
Şişli, Hatice Burcu
Demirci, Selami
Şahin, Fikrettin
Doğan, Ayşegül - Abstract:
- Abstract: Novel thiourea (5a, 5b ) and thiazolidinone derivatives (6a, 6b ) were synthesized by hybridizing molecules starting from the compound 6‐(4‐phenylpiperazin‐1‐yl)pyridin‐3‐amine (4 ) which is known to show anticancer activity. The synthesis of the leading compound was carried out by using 1‐(5‐nitropyridin‐2‐yl)‐4‐phenylpiperazine (3 ) which was obtained by a novel method of the reaction of 2‐chloro‐5‐nitropyridine (1 ) and N ‐phenylpiperazine (2 ). The structures of the compounds were confirmed using FTIR, 1 H NMR, 13 C NMR, HRMS spectroscopic methods and elemental analysis. The organic molecules were tested for their anticancer activities against prostate cancer (PC) cell lines: DU 145, PC‐3 and LNCaP. As the compound5a exerted the highest cytotoxic activity, IC50 concentrations of compound5a were further investigated in terms of morphology, colony‐forming ability, RNA expression, fragmented DNA and cell cycle distributions of PC cell lines. Overall data revealed that compound5a treatment induces apoptosis and DNA fragmentation in PC cell lines and inhibits cell cycle progression resulting in the accumulation of cells in either the G1 or the S phases. Abstract : Phenylpiperazine derivative blocks cell proliferation of prostate cancer (PC) cell lines. Phenylpiperazine derivative caused cell cycle arrest of PC cell lines. Phenylpiperazine derivative might be a potential anticancer agent for PC.
- Is Part Of:
- Chemical biology & drug design. Volume 94:Number 3(2019)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 94:Number 3(2019)
- Issue Display:
- Volume 94, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 94
- Issue:
- 3
- Issue Sort Value:
- 2019-0094-0003-0000
- Page Start:
- 1584
- Page End:
- 1595
- Publication Date:
- 2019-06-19
- Subjects:
- antitumor activity -- apoptosis -- cell cycle -- DNA fragmentation -- thiazolidinone -- thiourea
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.13575 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11816.xml